|
|
Article: Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.(PROPRIETARY PERSPECTIVES)
- Article from:
- Nutraceuticals World
- Article date:
- March 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Rodman Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The hallowed status that over-the-counter (OTC) drugs have enjoyed over the past several decades--ostensibly confidence-inspiring first line remedies for what ails many--is under siege. From pediatric to digestive meds, regulatory waves of resistance have been leveled. One "revelation" that continues to be "revealed" is that many of these OTC drugs lack substantial evidence of efficacy, as defined by randomized controlled trials (RCTs). Their approval came under the scrutiny of safety and NOT efficacy. Hmmm. Could a regulatory hole in the bulletproof vest adorning "drugs" create an opportunity for exploitation using natural bioactives?
One category of OTC drugs ...